2010 ◽  
Vol 18 ◽  
pp. S254
Author(s):  
L. Maneix ◽  
D. Ollitrault ◽  
N. Bigot ◽  
E. Duval ◽  
M. Bolla ◽  
...  

2011 ◽  
Vol 301 (3) ◽  
pp. H803-H812 ◽  
Author(s):  
Anne R. Diers ◽  
Katarzyna A. Broniowska ◽  
Victor M. Darley-Usmar ◽  
Neil Hogg

S-nitrosation of thiols in key proteins in cell signaling pathways is thought to be an important contributor to nitric oxide (NO)-dependent control of vascular (patho)physiology. Multiple metabolic enzymes are targets of both NO and S-nitrosation, including those involved in glycolysis and oxidative phosphorylation. Thus it is important to understand how these metabolic pathways are integrated by NO-dependent mechanisms. Here, we compared the effects of NO and S-nitrosation on both glycolysis and oxidative phosphorylation in bovine aortic endothelial cells using extracellular flux technology to determine common and unique points of regulation. The compound S-nitroso-l-cysteine (l-CysNO) was used to initiate intracellular S-nitrosation since it is transported into cells and results in stable S-nitrosation in vitro. Its effects were compared with the NO donor DetaNONOate (DetaNO). DetaNO treatment caused only a decrease in the reserve respiratory capacity; however, l-CysNO impaired both this parameter and basal respiration in a concentration-dependent manner. In addition, DetaNO stimulated extracellular acidification rate (ECAR), a surrogate marker of glycolysis, whereas l-CysNO stimulated ECAR at low concentrations and inhibited it at higher concentrations. Moreover, a temporal relationship between NO- and S-nitrosation-mediated effects on metabolism was identified, whereby NO caused a rapid impairment in mitochondrial function, which was eventually overwhelmed by S-nitrosation-dependent processes. Taken together, these results suggest that severe pharmacological nitrosative stress may differentially regulate metabolic pathways through both intracellular S-nitrosation and NO-dependent mechanisms. Moreover, these data provide insight into the role of NO and related compounds in vascular (patho)physiology.


2021 ◽  
Vol 328 ◽  
pp. 124827
Author(s):  
Zhenyi Wang ◽  
Jun Cheng ◽  
Xiangdong Zhang ◽  
Lechong Chen ◽  
Jianzhong Liu

Zygote ◽  
1998 ◽  
Vol 6 (2) ◽  
pp. 149-154 ◽  
Author(s):  
Martin Wilding ◽  
Brian Dale

We have injected soluble extracts of sperm from the ascidian Ciona intestinalis into oocytes of the same species to test whether these extracts can mimic the events of fertilisation. Injection of ascidian sperm extracts leads, after a delay of approximately 60 s, to a large calcium transient and repetitive pattern of calcium oscillations, mimicking the normal fertilisation response. The response was concentration-independent, suggesting a stimulatory mechanism in triggering the fertilisation response. We tested the pathway of calcium release in ascidian oocytes after injection of sperm extracts by preinjection of calcium release inhibitors. The data demonstrate that dual pathways to calcium release act at fertilisation in ascidians, as in other species. C. intestinalis oocytes are characterised by a nion channel in the plasma membrane that is gated uniquely by ADP ribose. We show that this channel is not gated by the injection of ascidian sperm extracts. Our data suggest that one metabolic pathway triggered by sperm, the release of nitric oxide, is not stimulated by sperm extracts and that several metabolic pathways are stimulated at fertilisation by more than one factor within sperm.


2019 ◽  
Vol 99 (1) ◽  
pp. 150-159
Author(s):  
Liangyu Hu ◽  
Bolin Xu ◽  
Yifan Wang ◽  
Mengzhi Wang ◽  
Hongrong Wang

Bovine mammary epithelial cells were used to evaluate the effects of different levels of Arginine (Arg) on enzymes related to Arg metabolism. A series of seven Arg concentrations in the medium as treatments were T0 (0.00 mg L−1) as control group, and T0.25 (69.50 mg L−1), T0.5 (139.00 mg L−1), T1 (278.00 mg L−1), T2 (556.00 mg L−1), T4 (1112.00 mg L−1), and T8 (2224.00 mg L−1) as experiment groups, respectively. The quantitative polymerase chain reaction and enzyme-linked immunosorbent assay analysis showed that the nitric oxide concentration, the expressions of endothelial nitric oxide synthase in mRNA, and enzyme level were all increased in response to enhanced Arg doses such that the T8 was the greatest group (P < 0.05). Four-fold Arg concentration improved gene expression and synthesis of arginase which then deceased when excessive Arg was supplied (P < 0.05). The expressions of ornithine aminotransferase mRNA and enzyme in T1 and T2 groups were significantly greater than that in the other groups (P < 0.05). Two-fold Arg was the optimum level for ornithine decarboxylase gene expression and enzyme synthesis among all seven treatments (P < 0.05). These somewhat various effects of Arg concentrations on four kinds of enzymes in different Arg metabolic pathways suggest that Arg might participate in regulating bovine mammary physiological function with an optimum concentration by influencing the enzymes in related metabolic pathways.


2021 ◽  
Author(s):  
Balbina J. Plotkin ◽  
Ira M. Sigar ◽  
Amber Kaminski

Metabolic pathways supporting long-term anaerobic cell viability have not been identified. The effect NO and H2S pathway effectors have on HeLa 229 cell viability was measured after 10 days anaerobic incubation. The addition of arginine or xanthine (NO pathway precursors) consistently increased HeLa cell viability by 13.1- and 4.4-fold, respectively. Allopurinol, a xanthine oxidase inhibitor, also increased viability, as compared to control levels. In contrast, inhibition of iNOS by 1400W increased cell viability by 79-fold. Regarding the H2S pathway, precursor cysteine enhanced viability by 9.8-fold with the greatest number of viable cells measured in response to the presence of a H2S donor (GYY4137), or an inhibitor of glutathione synthesis, propargylglycine (40- and 85-fold, respectively). These results demonstrate that the constitutive level of cell viability after extended (10 days) growth without oxygen can be modulated by affecting NO or H2S generating pathways.


2016 ◽  
Vol 94 (4) ◽  
pp. 297-305 ◽  
Author(s):  
Jimena Lavandera ◽  
Jorge Rodríguez ◽  
Silvina Ruspini ◽  
Roberto Meiss ◽  
Johanna Romina Zuccoli ◽  
...  

5-Aminolevulinic acid (ALA) seems to be responsible for the neuropsychiatric manifestations of acute intermittent porphyria (AIP). Our aim was to study the effect of ALA on the different metabolic pathways in the mouse brain to enhance our knowledge about the action of this heme precursor on the central nervous system. Heme metabolism, the cholinergic system, the defense enzyme system, and nitric oxide metabolism were evaluated in the encephalon of CF-1 mice receiving a single (40 mg/kg body mass) or multiple doses of ALA (40 mg/kg, every 48 h for 14 days). We subsequently found ALA accumulation in the encephalon of the mice. ALA also altered the brain cholinergic system. After one dose of ALA, a decrease in superoxide dismutase activity and a reduction in glutathione levels were detected, whereas malondialdehyde levels and catalase activity were increased. Heme oxygenase was also increased as an antioxidant response to protect the encephalon against injury. All nitric oxide synthase isoforms were induced by ALA, these changes were more significant for the inducible isoform in glial cells. In conclusion, ALA affected several metabolic pathways in mouse encephalon. Data indicate that a rapid response to oxidative stress was developed; however, with long-term intoxication, the redox balance was probably restored, thereby minimizing oxidative damage.


2008 ◽  
Vol 14 (4) ◽  
pp. 306-314 ◽  
Author(s):  
R. N. Rodionov ◽  
I. O. Blokhin ◽  
M. M. Galagudza ◽  
E. V. Shlyakhto ◽  
S. R. Lentz

Asymmetric dimethylarginine (ADMA) is a methylated derivative of the amino acid L-arginine that is receiving increasing attention as a cardiovascular risk factor. As a structural analog of L-arginine, ADMA can inhibit the activity of nitric oxide (NO) synthase, resulting in decreased NO production in blood vessels and other tissues. While substantial epidemiological and experimental evidence links elevated levels of ADMA with endothelial dysfunction and adverse vascular events, the causative role of ADMA in cardiovascular diseases remains still largely unproven. To definitively determine whether ADMA is a biomarker or a causative risk factor, a better understanding of the biochemistry, genetics, and pharmacology of the ADMA metabolic pathways is needed.


Sign in / Sign up

Export Citation Format

Share Document